Bridging communities in the field of nanomedicine
| Autor: | Luigi Calzolai, Vincent A. Hackley, Patrick Boisseau, Didier Bazile, Patricia Urbán, Margriet V. D. Z. Park, Sven Even F. Borgos, Gert Roebben, Karin Cederbrant, Lada Leyens, Blanka Halamoda-Kenzaoui, Simon Baconnier, Marina A. Dobrovolskaia, Valérie Zuang, Tiziana Di Francesco, Neill J. Liptrott, Gerrit Borchard, Anil K. Patri, Rogério Gaspar, Thierry Bastogne, René Thürmer, Matthias Roesslein, Belén Gracia, Gabriella Di Felice, Susanne Bremer-Hoffmann |
|---|---|
| Přispěvatelé: | Istituto Superiore per la Protezione e la Ricerca Ambientale (ISPRA), Commissariat à l'énergie atomique et aux énergies alternatives - Laboratoire d'Electronique et de Technologie de l'Information (CEA-LETI), Direction de Recherche Technologique (CEA) (DRT (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Centre de Recherche en Automatique de Nancy (CRAN), Université de Lorraine (UL)-Centre National de la Recherche Scientifique (CNRS) |
| Rok vydání: | 2018 |
| Předmět: |
Decision support system
workshop Standardization [SDV]Life Sciences [q-bio] Decision Making 010501 environmental sciences Toxicology 030226 pharmacology & pharmacy 01 natural sciences Article Bridging (programming) [SPI.AUTO]Engineering Sciences [physics]/Automatic immune effects 03 medical and health sciences 0302 clinical medicine Political science Surveys and Questionnaires Humans Regulatory science European commission critical quality attributes 0105 earth and related environmental sciences standardization Field (Bourdieu) General Medicine Decision Support Systems Clinical 3. Good health Joint research Nanomedicine regulatory science Engineering ethics |
| Zdroj: | Regulatory Toxicology and Pharmacology Regulatory Toxicology and Pharmacology, Elsevier, 2019, 106, pp.187-196. ⟨10.1016/j.yrtph.2019.04.011⟩ Regulatory Toxicology and Pharmacology, 2019, 106, pp.187-196. ⟨10.1016/j.yrtph.2019.04.011⟩ Regulatory toxicology and pharmacology |
| ISSN: | 1096-0295 0273-2300 |
| Popis: | An early dialogue between nanomedicine developers and regulatory authorities are of utmost importance to anticipate quality and safety requirements for these innovative health products. In order to stimulate interactions between the various communities involved in a translation of nanomedicines to clinical applications, the European Commission's Joint Research Centre hosted a workshop titled “Bridging communities in the field of Nanomedicine” in Ispra/Italy on the 27th −28th September 2017. Experts from regulatory bodies, research institutions and industry came together to discuss the next generation of nanomedicines and their needs to obtain regulatory approval. The workshop participants came up with recommendations highlighting methodological gaps that should be addressed in ongoing projects addressing the regulatory science of nanomedicines. In addition, individual opinions of experts relevant to progress of the regulatory science in the field of nanomedicine were summarised in the format of a survey. Graphical abstract Image 1 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect